STAT3 and neoplasm: Immunoprecipitation and Western blotting of tumor tissues showed that treatments with PS-acet.-STAT3 peptide downregulated STAT3 activation in HCT116 tumor xenografts (Figure 4B and Supplemental Figure 9, B and C).